Search

Search results

91 results found

TIGIT A2Ar-Dependent anti-uveitic Treg cells are a novel subset of Tregs associated with resolution of autoimmune uveitis

Publication: Journal Article

Muhammad, Fauziyya, Dawei Wang, Trisha McDonald, Marisa Walsh, Kayla Drenen, Alyssa Montieth, Stephen Foster, and Darren Lee. 2020. “TIGIT A2Ar-Dependent Anti-Uveitic Treg Cells Are a Novel Subset of Tregs Associated With Resolution of Autoimmune Uveitis”. J Autoimmun 111: 102441.

Notice of Retraction and Replacement. Kang et al. Association of statin use and high serum cholesterol levels with risk of primary open-angle glaucoma. JAMA Ophthalmol. 2019;137(7):756-765

Publication: Journal Article

Kang, Jae, Tahani Boumenna, Joshua Stein, Anthony Khawaja, Bernard Rosner, Janey Wiggs, and Louis Pasquale. 2020. “Notice of Retraction and Replacement. Kang et Al. Association of Statin Use and High Serum Cholesterol Levels With Risk of Primary Open-Angle Glaucoma. JAMA Ophthalmol. 2019;137(7):756-765”. JAMA Ophthalmol.

Association of the CAV1-CAV2 locus with normal-tension glaucoma in Chinese and Japanese

Publication: Journal Article

Lu, Shi Yao, Shi Song Rong, Zhenggen Wu, Chukai Huang, Kenji Matsushita, Tsz Kin Ng, Christopher Leung, et al. 2020. “Association of the CAV1-CAV2 Locus With Normal-Tension Glaucoma in Chinese and Japanese”. Clin Exp Ophthalmol 48 (5): 658-65.

Call for Papers: Addressing Bias and Reducing Discrimination in Health Professions Learning Environments

Blog: March 05, 2020

Deadline: April 8, 2020 Call for Papers for Special Journal Supplement The Josiah Macy Jr. Foundation invites submissions of original research papers and case studies related to the topic of Addressing Bias and Reducing Discrimination in Health Professions Learning Environments for possible...

NIH: Transgender People: Immunity, Prevention, and Treatment of HIV and STIs Research Grant

Blog: March 12, 2020

Deadline: May 11, 2020 The purpose of this grant is to support hypothesis-generating research among transgender people with the objective of characterizing the biological and immunological impact of the interventions (hormones, drugs and surgical) used for gender reassignment and their impact on...

Call for Abstracts - 38th GLMA Annual Conference on LGBTQ Health

Blog: March 13, 2020

Deadline: April 15, 2020 GLMA is excited to announce the Call for Abstracts for the 38th GLMA Annual Conference on LGBTQ Health, which will be held September 23-26, 2020 in Fort Lauderdale, FL! Abstracts must be submitted and completed online by 11:59PM Eastern on Wednesday, April 15, 2020...

What can the early days of AIDS teach us about today?

Events: Tuesday, Mar 17, 2020, 11:00am -Tuesday, Mar 17, 2020, 12:00pm

Topic: What can the early days of AIDS teach us about today?Date: Tuesday, March 17, 2020Time: 3:00 – 4:00 PM Eastern TimeJoin Zoom meeting: https://harvard.zoom.us/j/7735053140 Marshall Forstein, MDCambridge Health AllianceVice Chair for Education and TrainingProgram Co-Director, Adult Psychiatry...

News & Events

Page

Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults

Publication: Journal Article

Seminario-Vidal, Lucia, Daniela Kroshinsky, Stephen Malachowski, James Sun, Alina Markova, Thomas Beachkofsky, Benjamin Kaffenberger, et al. 2020. “Society of Dermatology Hospitalists Supportive Care Guidelines for the Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in Adults”. J Am Acad Dermatol 82 (6): 1553-67.

Reliability of Conjunctival Biopsy for Diagnosis of Ocular Mucous Membrane Pemphigoid: Redetermination of the Standard for Diagnosis and Outcomes of Previously Biopsy-Negative Patients

Publication: Journal Article

Anesi, Stephen, Laura Eggenschwiler, Mariantonia Ferrara, Pichaporn Artornsombudh, Marisa Walsh, and Stephen Foster. 2020. “Reliability of Conjunctival Biopsy for Diagnosis of Ocular Mucous Membrane Pemphigoid: Redetermination of the Standard for Diagnosis and Outcomes of Previously Biopsy-Negative Patients”. Ocul Immunol Inflamm, 1-8.